Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests

J Clin Microbiol. 2016 Oct;54(10):2521-9. doi: 10.1128/JCM.00346-16. Epub 2016 Jul 27.

Abstract

Rapid bedside inactivation of Ebola virus would be a solution for the safety of medical and technical staff, risk containment, sample transport, and high-throughput or rapid diagnostic testing during an outbreak. We show that the commercially available Magna Pure lysis/binding buffer used for nucleic acid extraction inactivates Ebola virus. A rapid bedside inactivation method for nucleic acid tests is obtained by simply adding Magna Pure lysis/binding buffer directly into vacuum blood collection EDTA tubes using a thin needle and syringe prior to sampling. The ready-to-use inactivation vacuum tubes are stable for more than 4 months, and Ebola virus RNA is preserved in the Magna Pure lysis/binding buffer for at least 5 weeks independent of the storage temperature. We also show that Ebola virus RNA can be manually extracted from Magna Pure lysis/binding buffer-inactivated samples using the QIAamp viral RNA minikit. We present an easy and convenient method for bedside inactivation using available blood collection vacuum tubes and reagents. We propose to use this simple method for fast, safe, and easy bedside inactivation of Ebola virus for safe transport and routine nucleic acid detection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disinfection / methods*
  • Hemorrhagic Fever, Ebola / diagnosis*
  • Hemorrhagic Fever, Ebola / virology*
  • Humans
  • Point-of-Care Systems*
  • RNA, Viral / isolation & purification*
  • Specimen Handling / methods*
  • Temperature
  • Time Factors
  • Virus Inactivation*

Substances

  • RNA, Viral

Grants and funding

This project is part of the EbolaMoDRAD consortium, which has received funding from the Innovative Medicine Initiative 2 Joint Undertaking under grant agreement 115843. This joint undertaking receives support from the European Union Horizon 2020 research and innovation programme and EFPIA.